Paradoxes of non-ST-segment elevation acute coronary in real-life clinical practice settings

Author:

Nesova A. K.1ORCID,Ryabov V. V.1ORCID

Affiliation:

1. Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia

Abstract

The aim of the review was to identify current barriers, "paradoxes", in the treatment of patients with non-ST segment elevation acute coronary syndrome (NSTE-ACS), based on a critical analysis of modern studies and identified evidence gaps.NSTE-ACS can be considered from the perspective of the following paradoxes: the risk-treatment paradox; risk stratification paradox; scope and timing of dual antiplatelet therapy; paradox of insufficient benefit of invasive treatment; age and comorbidity; tactics for multi-vessel coronary artery disease.A review of publications indexed in the Pubmed and Russian Science Citation Index (RSCI) databases was carried out. The search depth was 10 years (from 2013 to 2023). The search resulted in 328 studies, of which 45 were used to write the final review.

Publisher

Silicea - Poligraf, LLC

Reference45 articles.

1. Everett C, Fox K, Reynolds C, et al. Evaluation of the impact of the GRACE risk score on the management and outcome of patients hospitalised with non-ST elevation acute coronary syndrome in the UK: protocol of the UKGRIS cluster-randomised registry-based trial. BMJ Open. 2019;9(9):e032165. doi:10.1136/bmjopen-2019-032165.

2. Barbarash OL, Komarov AL, Panchenko EP, et al. Eurasian clinical guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndrome (NSTE-ACS). Eurasian heart journal. 2021;(4):6-59. (In Russ.) doi:10.38109/2225-1685-2021-4-6-59.

3. Takeji Y, Shiomi H, Morimoto T, et al. CREDO-Kyoto PCI/CABG Registry Cohort-2 and the CREDO-Kyoto PCI/CABG Registry Cohort-3 Investigators. Demographics, practice patterns and long-term outcomes of patients with non-ST-segment elevation acute coronary syndrome in the past two decades: the CREDO-Kyoto Cohort-2 and Cohort-3. BMJ Open. 2021;11(2):e044329. doi:10.1136/bmjopen-2020-044329.

4. Alekyan BG, Boytsov SA, Manoshkina EM, et al. Myocardial revascularization in Russian Federation for acute coronary syndrome in 2016-2020. Kardiologiia. 2021;61(12):4-15. (In Russ.) doi:10.18087/cardio.2021.12.n1879.

5. Barbarash OL, Kashtalap VV, Bykova IS, et al. Approaches to diagnosis and treatment of patients with non-ST segment elevation acute coronary syndrome in Russian hospitals. Record-3 registry data. The Siberian Journal of Clinical and Experimental Medicine. 2017;32(3):88-94. (In Russ.) doi:10.29001/2073-8552-2017-32-3-88-94.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3